CG Oncology, Inc. Common stock (CGON)
CGON Stock Price Chart
Explore CG Oncology, Inc. Common stock interactive price chart. Choose custom timeframes to analyze CGON price movements and trends.
CGON Company Profile
Discover essential business fundamentals and corporate details for CG Oncology, Inc. Common stock (CGON) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
113.00
Website
https://cgoncology.comCEO
Arthur Kuan
Description
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.
CGON Financial Timeline
Browse a chronological timeline of CG Oncology, Inc. Common stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.57.
Earnings released on 8 Aug 2025
EPS came in at -$0.54 falling short of the estimated -$0.49 by -10.20%.
Earnings released on 13 May 2025
EPS came in at -$0.45 falling short of the estimated -$0.39 by -15.38%, while revenue for the quarter reached $52.00K , missing expectations by -56.00%.
Earnings released on 28 Mar 2025
EPS came in at -$0.48 falling short of the estimated -$0.41 by -17.07%, while revenue for the quarter reached $456.00K , beating expectations by +267.89%.
Earnings released on 14 Nov 2024
Earnings released on 8 Aug 2024
EPS came in at -$0.28 surpassing the estimated -$0.42 by +33.33%, while revenue for the quarter reached $111.00K .
Earnings released on 9 May 2024
EPS came in at -$0.36 falling short of the estimated -$0.35 by -2.86%, while revenue for the quarter reached $529.00K .
Earnings released on 26 Mar 2024
CGON Stock Performance
Access detailed CGON performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.